title: A rare adverse effect of montelukast treatment: ecchymosis.
abstract: Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients montelukast should be discontinued.
authors: Department of Family Medicine, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.
authors: Cenk
authors: C
authors: Aypak
authors: Özlem
authors: Ö
authors: Türedi
authors: Nisa
authors: N
authors: Solmaz
authors: Hülya
authors: H
authors: Yıkılkan
authors: Süleyman
authors: S
authors: Görpelioğlu
mesh_terms: D000085:Acetates / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D003521:Cyclopropanes; D004438:Ecchymosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D020024:Leukotriene Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D035002:Lower Extremity; D011804:Quinolines / Q000008:administration & dosage / Q000009:adverse effects*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy; D013440:Sulfides
chemical_list: D000085:Acetates; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast
keywords: adverse effects; bruising; leukotriene antagonists; montelukast